4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001799191-24-000041
Chief Medical Officer returned 3,002 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Podnos Yale Chief Medical Officer | 2024-11-20 | Returned to the company | −1,709 | $0.14 | $232 | 74,261 | D: show line 1 in the form |
| Podnos Yale Chief Medical Officer | 2024-11-20 | Returned to the company | −267 | $0.14 | $36 | 73,994 | D: show line 2 in the form |
| Podnos Yale Chief Medical Officer | 2024-11-20 | Returned to the company | −1,026 | $0.14 | $140 | 72,968 | D: show line 3 in the form |
Loading xslF345X05/wk-form4_1732231216.xml…